161 related articles for article (PubMed ID: 37113717)
1. Low level of BRCA2 in peripheral blood lymphocytes is associated with an increased risk for head and neck squamous cell carcinoma (HNSCC) in a population of North-East India: a case-control study.
Das S; Bhowmik A; Bhattacharjee A; Choudhury B; Naiding M; Dhar B; Laskar AK; Pandit J; Ghosh SK; Choudhury Y
Ecancermedicalscience; 2023; 17():1503. PubMed ID: 37113717
[TBL] [Abstract][Full Text] [Related]
2. XPD, APE1, and MUTYH polymorphisms increase head and neck cancer risk: effect of gene-gene and gene-environment interactions.
Das S; Bhowmik A; Bhattacharjee A; Choudhury B; Naiding M; Laskar AK; Ghosh SK; Choudhury Y
Tumour Biol; 2015 Sep; 36(10):7569-79. PubMed ID: 25916209
[TBL] [Abstract][Full Text] [Related]
3. DNA repair genes XPC, XPD, XRCC1, and XRCC3 are associated with risk and survival of squamous cell carcinoma of the head and neck.
Farnebo L; Stjernström A; Fredrikson M; Ansell A; Garvin S; Thunell LK
DNA Repair (Amst); 2015 Jul; 31():64-72. PubMed ID: 26001739
[TBL] [Abstract][Full Text] [Related]
4. Influence of XPD and APE1 DNA repair gene polymorphism on bladder cancer susceptibility in north India.
Gangwar R; Ahirwar D; Mandhani A; Mittal RD
Urology; 2009 Mar; 73(3):675-80. PubMed ID: 19041121
[TBL] [Abstract][Full Text] [Related]
5. Associated risk of XRCC1 and XPD cross talk and life style factors in progression of head and neck cancer in north Indian population.
Kumar A; Pant MC; Singh HS; Khandelwal S
Mutat Res; 2012 Jan; 729(1-2):24-34. PubMed ID: 21945240
[TBL] [Abstract][Full Text] [Related]
6. Reduced expression of DNA repair genes (XRCC1, XPD, and OGG1) in squamous cell carcinoma of head and neck in North India.
Kumar A; Pant MC; Singh HS; Khandelwal S
Tumour Biol; 2012 Feb; 33(1):111-9. PubMed ID: 22081374
[TBL] [Abstract][Full Text] [Related]
7. MUTYH Tyr165Cys, OGG1 Ser326Cys and XPD Lys751Gln polymorphisms and head neck cancer susceptibility: a case control study.
Sliwinski T; Przybylowska K; Markiewicz L; Rusin P; Pietruszewska W; Zelinska-Blizniewska H; Olszewski J; Morawiec-Sztandera A; Mlynarski W; Majsterek I
Mol Biol Rep; 2011 Feb; 38(2):1251-61. PubMed ID: 20571908
[TBL] [Abstract][Full Text] [Related]
8. Implications of XRCC1, XPD and APE1 gene polymorphism in North Indian population: a comparative approach in different ethnic groups worldwide.
Gangwar R; Manchanda PK; Mittal RD
Genetica; 2009 May; 136(1):163-9. PubMed ID: 18946634
[TBL] [Abstract][Full Text] [Related]
9. Genetic polymorphisms in DNA repair genes OGG1, APE1, XRCC1, and XPD and the risk of age-related cataract.
Zhang Y; Zhang L; Song Z; Sun DL; Liu HR; Fu SB; Liu DR; Liu P
Ophthalmology; 2012 May; 119(5):900-6. PubMed ID: 22306120
[TBL] [Abstract][Full Text] [Related]
10. Polymorphisms of DNA repair genes and risk of squamous cell carcinoma of the head and neck in young adults.
Kostrzewska-Poczekaj M; Gawęcki W; Illmer J; Rydzanicz M; Gajecka M; Szyfter W; Szyfter K
Eur Arch Otorhinolaryngol; 2013 Jan; 270(1):271-6. PubMed ID: 22427030
[TBL] [Abstract][Full Text] [Related]
11. The influence of XPD, APE1, XRCC1, and NBS1 polymorphic variants on DNA repair in cells exposed to X-rays.
Gdowicz-Klosok A; Widel M; Rzeszowska-Wolny J
Mutat Res; 2013 Jul; 755(1):42-8. PubMed ID: 23669291
[TBL] [Abstract][Full Text] [Related]
12. Specific combinations of DNA repair gene variants and increased risk for non-small cell lung cancer.
Popanda O; Schattenberg T; Phong CT; Butkiewicz D; Risch A; Edler L; Kayser K; Dienemann H; Schulz V; Drings P; Bartsch H; Schmezer P
Carcinogenesis; 2004 Dec; 25(12):2433-41. PubMed ID: 15333465
[TBL] [Abstract][Full Text] [Related]
13. DNA repair gene X-ray repair cross-complementing group 1 and xeroderma pigmentosum group D polymorphisms and risk of prostate cancer: a study from North India.
Mandal RK; Gangwar R; Mandhani A; Mittal RD
DNA Cell Biol; 2010 Apr; 29(4):183-90. PubMed ID: 20070155
[TBL] [Abstract][Full Text] [Related]
14. Peripheral blood monocyte and T-lymphocyte activation levels at diagnosis predict long-term survival in head and neck squamous cell carcinoma patients.
Aarstad HJ; Vintermyr OK; Ulvestad E; Aarstad HH; Kross KW; Heimdal JH
APMIS; 2015 Apr; 123(4):305-14. PubMed ID: 25801083
[TBL] [Abstract][Full Text] [Related]
15. The DNA damage response network in the treatment of head and neck squamous cell carcinoma.
Psyrri A; Gkotzamanidou M; Papaxoinis G; Krikoni L; Economopoulou P; Kotsantis I; Anastasiou M; Souliotis VL
ESMO Open; 2021 Apr; 6(2):100075. PubMed ID: 33714009
[TBL] [Abstract][Full Text] [Related]
16. Xeroderma pigmentosum, complementation group D expression in H1299 lung cancer cells following benzo[a]pyrene exposure as well as in head and neck cancer patients.
Lin CS; Chiou WY; Lee KW; Chen TF; Lin YJ; Huang JL
J Toxicol Environ Health A; 2016; 79(1):39-47. PubMed ID: 26731659
[TBL] [Abstract][Full Text] [Related]
17. Impact of Polymorphism in Base Excision Repair and Nucleotide Excision Repair Genes and Risk of Cervical Cancer: A Case-Control Study.
Datkhile KD; Durgawale PP; Patil MN; Gudur RA; Gudur AK; Patil SR
Asian Pac J Cancer Prev; 2022 Apr; 23(4):1291-1300. PubMed ID: 35485688
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of antioxidant network proteins as novel prognostic biomarkers for head and neck cancer patients.
Wicker CA; Takiar V; Suganya R; Arnold SM; Brill YM; Chen L; Horbinski CM; Napier D; Valentino J; Kudrimoti MR; Yu G; Izumi T
Oral Oncol; 2020 Dec; 111():104949. PubMed ID: 32801084
[TBL] [Abstract][Full Text] [Related]
19. Deregulation of base excision repair gene expression and enhanced proliferation in head and neck squamous cell carcinoma.
Mahjabeen I; Ali K; Zhou X; Kayani MA
Tumour Biol; 2014 Jun; 35(6):5971-83. PubMed ID: 24622884
[TBL] [Abstract][Full Text] [Related]
20. Association between genetic polymorphisms in XPD and XRCC1 genes and risks of non-small cell lung cancer in East Chinese Han population.
Du Y; He Y; Mei Z; Qian L; Shi J; Jie Z
Clin Respir J; 2016 May; 10(3):311-7. PubMed ID: 25308691
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]